文献速递肝病

肝硬化住院患者多中心队列中呼吸衰竭发生的预测因素

Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2023-11-08

研究前瞻性纳入北美14个中心的511例肝硬化住院患者,在无特利加压素可用时期,15%发生呼吸衰竭。入院时急性肾损伤、消化道出血和高MELD-Na可预测呼吸衰竭;住院期间院内感染、白蛋白使用及其他器官衰竭与呼吸衰竭风险相关。

要点

  • 肝硬化住院患者中15%发生呼吸衰竭,与不良预后相关。
  • 入院时急性肾损伤、消化道出血及高MELD-Na是呼吸衰竭的预测因素。
  • 住院期间院内感染、白蛋白使用及循环衰竭等与呼吸衰竭风险独立相关。

核心结论

  • 在未暴露于特利加压素的多中心肝硬化住院患者中,15%发生呼吸衰竭,入院时急性肾损伤、消化道出血和高MELD-Na者风险最高,住院期间发生院内感染、其他器官衰竭或使用白蛋白者风险也高。

研究设计与样本

  • 前瞻性多中心北美肝硬化住院患者队列,共纳入14个中心的511例患者,中位年龄57岁,入院时MELD-Na中位数23。

主要发现

  • 呼吸衰竭发生率为15%,急性肾损伤发生率为24%,院内感染发生率为11%。
  • 发生呼吸衰竭的患者中白蛋白使用比例为83%,未发生呼吸衰竭的患者为59%(P < 0.0001);发生呼吸衰竭的患者白蛋白使用剂量为269.5 ± 210.5 g,未发生呼吸衰竭的患者为208.6 ± 186.1 g(P = 0.01)。
  • 多因素回归显示,院内感染(OR = 4.02,P = 0.0004)、消化道出血(OR = 3.1,P = 0.002)、白蛋白使用(OR = 2.93,P = 0.01)、急性肾损伤(OR = 3.26,P = 0.008)和循环衰竭(OR = 3.73,P = 0.002)与呼吸衰竭风险相关。

临床怎么用

  • 作者认为,仔细的容量监测以及预防院内呼吸道感染和肾或循环衰竭可能降低呼吸衰竭风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hospitalized patients with cirrhosis can develop respiratory failure (RF), which is associated with a poor prognosis, but predisposing factors are unclear. METHODS: We prospectively enrolled a multicenter North American cirrhosis inpatient cohort and collected admission and in-hospital data (grading per European Association for the Study of Liver-Chronic Liver Failure scoring system, acute kidney injury [AKI], infections [admission/nosocomial], and albumin use) in an era when terlipressin was not available in North America. Multivariable regression to predict RF was performed using only admission day and in-hospital events occurring before RF. RESULTS: A total of 511 patients from 14 sites (median age 57 years, admission model for end-stage liver disease [MELD]-Na 23) were enrolled: RF developed in 15%; AKI occurred in 24%; and 11% developed nosocomial infections (NI). At admission, patients who developed RF had higher MELD-Na, gastrointestinal (GI) bleeding/AKI-related admission, and prior infections/ascites. During hospitalization, RF developers had higher NI (especially respiratory), albumin use, and other organ failures. RF was higher in patients receiving albumin (83% vs 59%, P < 0.0001) with increasing doses (269.5 ± 210.5 vs 208.6 ± 186.1 g, P = 0.01) regardless of indication. Admission for AKI, GI bleeding, and high MELD-Na predicted RF. Using all variables, NI (odds ratio [OR] = 4.02, P = 0.0004), GI bleeding (OR = 3.1, P = 0.002), albumin use (OR = 2.93, P = 0.01), AKI (OR = 3.26, P = 0.008), and circulatory failure (OR = 3.73, P = 0.002) were associated with RF risk. DISCUSSION: In a multicenter inpatient cirrhosis study of patients not exposed to terlipressin, 15% of patients developed RF. RF risk was highest in those admitted with AKI, those who had GI bleeding on admission, and those who developed NI and other organ failures or received albumin during their hospital course. Careful volume monitoring and preventing nosocomial respiratory infections and renal or circulatory failures could reduce this risk.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, Kamath PS, Reddy KR, et al. Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis. Am J Gastroenterol. 2023. PMID: 37938163. doi:10.14309/ajg.0000000000002574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。